Insulin resistance in patients with familial combined hyperlipidemia and coronary artery disease

American Journal of Cardiology

Volumn 80, Issue 11, 1997, Pages 1484-1487

  Ascaso, Juan F ^a   Lorente, Rosario ^a   Merchante, Angel ^a   Real, José T ^a   Priego, Antonia ^a   Carmena, Rafael ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; FAMILIAL DISEASE; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL;

BLOOD GLUCOSE; CORONARY DISEASE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; INSULIN; INSULIN RESISTANCE; LIPOPROTEINS; MALE; MIDDLE AGED; PEDIGREE; PHENOTYPE; RISK FACTORS;

EID: 0030812547     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00737-6     Document Type: Article

References (17)

1. Goldstein JL, Hazzard WR, Schrott HG, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest. 52:1973;1533-1543.
2. Castro-Cabezas M, de Bruin TWA, de Valk HW, Shoulders CC, Jansen H, Erkelens EW. Impaired fatty acid metabolism in familial combined hyperlipidemia a mechanism associating hepatic apolipoprotein B overproduction and insulin resistance . J Clin Invest. 92:1993;160-168.
3. Genest JJ, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, Silberman SR, Wilson PWF, Salem DN, Schaeffer J. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation. 85:1992;2025-2033.
4. Grundy SM, Chait A, Brunzell JD. Familial combined hyperlipidemia workshop. Arteriosclerosis. 7:1987;203-207.
5. Hunt SC, Hopkins PN, Stults BM, Kuida H, Ramirez ME, Lalouel JM, Williams RR. Apolipoprotein, low density lipoprotein subfraction and insulin association in familial combined hyperlipidemia. Arteriosclerosis. 9:1989;335-344.
6. Kwiterovich PO Jr, Coresh J, Bachorick PS. Prevalence of hyperapobeta-lipoproteinemia and other lipoprotein phenotypes in men (aged ≤50) and women (≤60 years) with coronary artery disease. Am J Cardiol. 71:1993;640-645.
7. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med. 18:1988;36-39.
8. Ascaso JF, Sales J, Merchante A, Real J, Lorente R, Martinez-Valls J, Carmena R. Influence of obesity on plasma lipoproteins, glycaemia and insulinaemia in patients with familial combined hyperlipidaemia. Int J Obes Relat Metab Disord. 21:1997;360-366.
9. Labeur C, Michiels G, Burg J, Usher DC, Rosseneau M. Lipoprotein (a) quantified by an enzyme-linked immunosorbent assay with monoclonal antibodies. Clin Chem. 35:1989;1380-1384.
10. Milies J, Glasscock R, Aikens J, Gerich J, Haymond M. A microfluorimetric method for the determination of free fatty acids in plasma. J Lipid Res. 24:1983;96-99.
11. Nichols AV, Krauss RM, Musliner TA. Nondenaturaring polyacrylamide gradient gel electrophoresis. Segrest JP, Albers JJ. Methods in Enzymology. 1986;417-431 Academic Press, Plasma lipoprotein. Preparation, Structure and Molecular Biology. Orlando.
12. Pacini C, Bergman RN. MINMOD a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test . Comput Methods Programs Biomed. 23:1986;113-122.
13. Stout RW. Insulin and atherosclerosis. Dev Cardiovasc Med. 125:1992;165-201.
14. Raitakari OT, Porkka KVK, Rom̈enaa T, Knip M, Uhari M, Akerblom HK, Viikari JSA. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The Cardiovascular Risk in Young Finns Study. Diabetologia. 38:1995;1042-1050.
15. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 334:1996;952-957.
16. Haffner SM, Mykkänen L, Robbins D, Valdez R, Miettinen H, Howard BV, Stern MS, Bowsher R. A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non diabetic subjects. Diabetologia. 38:1995;1328-1336.
17. Krauss RM. Dense low-density lipoprotein and coronary heart disease. Am J Cardiol. 75:1995;53B-57B.